New Pharmacovigilance Legislation in the Eu

被引：0

作者：

Farzan, J. ^{[1
]}

机构：

[1] Paul Ehrlich Inst, D-63225 Langen, Germany

来源：

PSYCHOPHARMAKOTHERAPIE | 2011年 / 18卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：267 / 269

页数：3

共 50 条

[21] European Union pharmacovigilance capabilities: potential for the new legislation
Borg, John Joseph
Tanti, Amy
Kouvelas, Dimitrios
Lungu, Calin
Pirozynski, Michal
Serracino-Inglott, Anthony
Aislaitner, George
THERAPEUTIC ADVANCES IN DRUG SAFETY, 2015, 6 (04) : 120 - 140
[22] New Pharmacovigilance Legislation: A Call to Arms to the Pharmacoepidemiology Community
Blackburn, Stella C. F.
Arlett, Peter R.
Evans, Stephen J.
Perez-Gutthann, Susana
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 339 - 339
[23] Getting to grips with the new European Union pharmacovigilance legislation
Waller, Patrick
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (05) : 544 - 549
[24] New EU rules on funding of reinforced pharmacovigilance
Reactions Weekly, 2014, 1492 (1) : 2 - 2
[25] Author’s Reply to Borg et al. Comment on: “EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”
Begoña Calvo
Drug Safety, 2014, 37 : 125 - 126
[26] Author's Reply to Borg et al. Comment on: "EU's New Pharmacovigilance Legislation: Considerations for Biosimilars"
Calvo, Begona
DRUG SAFETY, 2014, 37 (02) : 125 - 126
[27] New food additives legislation in the EU
Debeuckelaere, Wim
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[28] Patients' Knowledge of ADR in the Eve of the New European Pharmacovigilance Legislation
Lebanova, V.
Getov, I. N.
DRUG SAFETY, 2012, 35 (10) : 894 - 894
[29] Risk Management Plans: Implementation of the New Pharmacovigilance Legislation in Mexico
Duran, H.
Alatorre, R.
Lara, O.
DRUG SAFETY, 2018, 41 (11) : 1244 - 1245
[30] Current issues and legislation in pharmacovigilance
Van der Velden, JW
PHARMACOPSYCHIATRY, 2005, 38 (01) : 66 - 66

← 1 2 3 4 5 →